title: [Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].
authors.forename: Lin
authors.initials: L
authors.lastname: Chen
authors.forename: Xu-dong
authors.initials: XD
authors.lastname: Wei
authors.forename: Qin-song
authors.initials: QS
authors.lastname: Yin
mesh_terms: D015250:Aclarubicin / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005984:Glutethimide / Q000008:administration & dosage / Q000031:analogs & derivatives; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003561:Cytarabine; C088366:cyclohexylaminoglutethimide; D016179:Granulocyte Colony-Stimulating Factor; D015250:Aclarubicin; D005984:Glutethimide